Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › LALPATHLAB

LALPATHLAB

Dr. Lal Path Labs Ltd.
Small-capHealthcare ↗

What the six lenses say about LALPATHLAB — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹1901.9
2026-09-08
VWAP · 1Y anchor
₹1577
+20.6% from VWAP
P/E · TTM
63.1×
TTM EPS ₹30.1
52-week range
92%
position low→high
RSI(14)
53
momentum

Own sector index

Healthcare ↗
Neutral

1M

-1.1%

3M

+7.1%

1Y

+14.5%

Breadth >EMA21

55%

How LALPATHLAB’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
5.5
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Small-cap cohortDRaw
TechnicalD790›

The actual numbers

Price vs VWAP (1y)+20.6%
EMA trend stackUp · 21>50>200
Price vs 200-EMA+16.5%
Price vs 50-EMA+3.9%
RSI(14)53
RS vs Nifty 500 · 3M+18.6%
RS vs sector · 3M+15.9%
52-week range92%
Volume vs 30d avg0.32×
Volume vs 60d avg0.18×
ATR(14) · volatility52.9
Bollinger width · vol contraction0.048
FundamentalD866›

The actual numbers

Return on equity (ROE)22.5%
Return on capital (ROCE)28.3%
Operating margin25.0%
Net margin18.4%
Revenue growth · YoY+12.3%
EPS growth · YoY-38.7%
Debt / equity0.08×

Full 8-quarter history in the financials table below.

ValuationD37›

The actual numbers

P/E (TTM)63.1×
TTM EPS₹30.1
52-week range92%
CatalystD745›

The actual numbers

Earnings & momentum41
Capital actions29
Governance95

Every filing in the corporate-announcements panel below.

FlowD450›

The actual numbers

Promoter holding53.2%
Delivery · 30d avg56.9%
Up/down-day asymmetry0.8pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D7 + D4 ) ÷ 2 = 5.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Highest
86
Conviction score 86/100 · avg-decile strength 5.5/10
Conviction score86/100›
TechnicalD7›
FundamentalD8›
ValuationD3›
CatalystD7›
FlowD4›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+1.8pp
-0.4pp
+2.1pp
+20.2pp
+42.6pp
+23.1pp
Nifty 500
Broad-market baseline
+1.7pp
-0.4pp
+1.1pp
+18.6pp
+36.8pp
+17.8pp
Sector
Own-sector index
—
—
-0.3pp
+15.9pp
+28.2pp
+4.6pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

LALPATHLAB daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
1901.90+24.40

Relative strength

RS vs baseline · rebased to 100

LALPATHLAB ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
114.26+1.94

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)602660597603670731660703
↳ change QoQ—+9.7%-9.6%+1.1%+11.1%+9.1%-9.7%+6.5%
EBITDA (₹cr)191224179169192224179187
EBITDA margin31.7%34.0%30.0%28.0%28.7%30.6%27.1%26.6%
PAT (₹cr)1081319815613415291132
↳ change QoQ—+21.3%-25.0%+59.0%-14.1%+13.4%-40.1%+45.1%
Net margin17.9%19.8%16.4%25.9%20.0%20.8%13.8%18.8%
EPS (₹)12.7915.5211.609.267.908.995.407.84
D/E————————
YoY growth · Mar '26Revenue +16.6% YoYPAT -15.4% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 27 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 19 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 6 Aug '26
    LOWgovernance
    ESOP/ESOS/ESPS
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 30 Jul '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 26 Jul '26
    MEDIUMgovernance
    Change in Director(s)
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 24 Jul '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 24 Jul '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 24 Jul '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 24 Jul '26
    LOWgovernance
    ESOP/ESOS/ESPS
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 24 Jul '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 24 Jul '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 24 Jul '26
    MEDIUMcapital
    Dividend
    ›

    A dividend declaration — a cash return to shareholders.

    View original filing on NSE ↗
  • 24 Jul '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 17 Jul '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 17 Jul '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds LALPATHLAB

Mutual funds holding LALPATHLAB (10)

FundWeightAUM ₹crGrade
HDFC Flexi Cap Gr0.72%1,10,736
SBI Large & Midcap Reg Gr0.59%42,325
Aditya BSL Flexi Cap Gr1.36%28,112
UTI Flexi Cap Reg Gr2.01%24,036
HDFC ELSS TaxSaver Gr1.35%16,095
Sundaram Mid Cap Gr1.54%14,504
UTI Mid Cap Reg Gr1.15%12,379
ICICI Pru Smallcap Instl Gr1.10%9,533
ICICI Pru Smallcap Gr1.10%9,533
Nippon India Pharma Gr2.05%9,279

ETFs holding LALPATHLAB (10)

ETFWeightGrade
Zerodha Nifty Smallcap 100 ETF1.26%
Mirae Asset Nifty 500 Healthcare ETF1.07%
Edelweiss Nifty500 Mltcp Mmt Ql 50 ETF0.94%
Motilal Oswal BSE Healthcare ETF0.91%
ANGEL ONE NIFTY TTL MKT MOMT QUAL 50 ETF0.84%
DSP Nifty Smallcap 250 ETF0.72%
HDFC Nifty Smallcap 250 ETF0.69%
Motilal Oswal Nifty Smallcap 250 ETF0.69%
Mirae Asset Nifty Smallcap 250 ETF0.69%
Groww Nifty Smallcap 250 ETF0.69%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare